RxDoctor Payments Data

Andrew Appel, MD

Orthopaedic Surgery of the Spine · Orlando, FLNPI 1538102124

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $121,101 of the $201,288 with a category attached, or 60.2%. Precision Spine, Inc. accounts for 99.8% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $79,880 and has fallen 100.0% since, to $22 in 2024.

$201,288in general payments, 2019–2025

Across 25 payments — averaging $8051.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Precision Spine, Inc.$201K
  • Si-bone, Inc.$87
  • Medtronic$85
  • CTL Medical Corporation$63
  • DJO, LLC$55
  • Johnson & Johnson$44
  • plus $37 from 2 others

What the payments were for

  • Royalty or licence$121,10160%
  • Consulting fees$79,81740%
  • Food & beverage$3700%

General payments by program year

19
20
21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$201,288 in reported general payments places this provider in the 80th percentile of 159 orthopaedic surgery of the spine providers in Florida.

See all orthopaedic surgery of the spine providers in Florida

Medicare billing

Part B allowed, 2024
$3,955
Medicare patients
17
Services billed
29

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin15$132
Meloxicam35$49

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →